Vivos Therapeutics Receives First-Ever FDA 510(k) Clearance for Oral Device Treatment of Severe Obstructive Sleep Apnea
In a groundbreaking development, Vivos Therapeutics, a renowned medical device company specializing in sleep-related breathing disorders, has achieved a historic milestone – receiving the first-ever FDA 510(k) clearance for its oral device designed to treat severe obstructive sleep apnea (OSA). This clearance not only validates the effectiveness and safety of Vivos Therapeutics’ flagship product, the […]